バイオテクノロジー業界の新興企業からの教訓

Lessons Learned from the Current Crop of Biotech Startups

発行	Decision Resources, Inc.
出版日	2008年08月	商品コード	71945
ページ情報	英文 40 Pages
価格	US$ 2,250 換算 ¥ 181,552 (税抜) PDF by E-mail (Global License)

概要
原文目次
関連レポート

原文目次

Abstract

Introduction

The initial public offering (IPO) market for biotech and specialty pharma companies has been nearly lifeless in 2008. Investment bankers are unimpressed by the performance of these companies, and money managers are reluctant to support a negative trend. The other side of intense pessimism, however, is that money accumulates on the sidelines where life science investors ultimately become impatient with money market returns and look for places to put risk capital to work. We demystify the best way to navigate the startup route through three in-depth Spectrum Expert Commentaries. A fresh and comprehensive look at IPOs and industry trends demonstrates that the future is not all bleak.

Get the Answers You Need to Shape Your Strategy

Having raised enough money, filed the sufficient forms, and ensured your leading compound is in the intended phase of development are all important factors in the decisions companies make before going public. What steps, when implemented, will further the likelihood of a successful IPO filing? How can competitors' strategies be interpreted based on their decisions?
Despite the unstable state of today' s economy, not every startup is aiming to be acquired by a larger firm. What exit strategies are particularly common among those biotech startups that are performing well? What motivates the investors that are observing from the sidelines?
Expert opinion is unanimous: establishing a strong game plan early in the process of the pathway to going public - and sticking to it - is essential. How can a biopharma or diagnostics company looking to invest in a startup influence that process to create a win-win for all parties involved?

Scope

Overview of the biotechnology startup landscape: market overview, market performance, 2007- 2008 IPOs, status of startups' lead compounds in development.
Company profiles: detailed company profiles of six startups that are making strides in today' s tough economy - Molecular Insight Pharmaceuticals, NeurogesX, NovaBay Pharmaceuticals, Optimer Pharmaceuticals, Orexigen Therapeutics, and Rosetta Genomics.
Spectrum Expert Commentaries: in-depth analysis from innovative, accomplished, and renowned scientist entrepreneurs who provide valuable strategic insight and advice to early-stage companies.
Specific insight for young companies: advice on how to plan for the IPO road show; issues to consider regarding investor relations; and the advantages of a strong management team.

Executive Summary
- Strategic Considerations
- Stakeholder Implications
Overview
State of the Market
Molecular Insight Pharmaceuticals: Focus on Core Technology
NeurogesX: Consider the Peripherals
NovaBay Pharmaceuticals: Target Unmet Need
Optimer Pharmaceuticals: Offer a Unique Perspective
Orexigen Therapeutics: Build Synergies
Rosetta Genomics: Form Timely Partnerships
Advice to Young Companies
- Choosing a Strategy: The IPO Road Show
- Consider Investor Relations
- Solid Upper Management
Outlook

Spectrum Expert Commentaries

Nanotechnology: From Academic Innovations to Cutting-Edge Companies
- Nanotechnology in Medicine
- Nanotechnology for Biotech and Pharma
- BIND and Selecta
The Trials and Tribulations of Going Public
- One Piece at a Time
- Parting Advice for CEOs of Tomorrow' s Public Companies
How to Get Your Research Out of the Laboratory:
A Primer for the Academic Entrepreneur
- Find a Mentor (or Several)
- Document Your Research
- Disclose Early and Often
- “I Don' t Want to Make Money from My Research. I' m a Scientist.”
- Work with Your Technology Office on the Patent Filing
- Know When Your Technology Is Ready to Be Licensed
- Become Very Familiar with Your Institution' s Conflict of Interest Polices
- Should I License the Technology to an Existing Company or Start a New Company?
  - Licensing to an Existing Company
  - Starting a Company Around Your Technology
- What Happens to the Income Generated by the License?
- Getting Started on a Startup
  - Make Sure Your Patents Are in Place
  - It' s All About the Product!
  - Will the Company Be Virtual or Real?
  - Will You Work at the Company or Remain in Your Academic Position?
  - Form a Team
  - Develop a Plan
  - How Much Money Do I Need?
  - What Kind of Investors Will You Approach?
  - Will You Take a Position on the Board of Directors?
  - What Are the Most Common Mistakes to Avoid?
  - Why Bother?